<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2024-19-33-37</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-3908</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Электрокинетические показатели эритроцитов  как диагностические критерии преэклампсии</article-title><trans-title-group xml:lang="en"><trans-title>Electrokinetic indices of erythrocytes as diagnostic criteria  for preeclampsia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8284-8117</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гаспарян</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gasparyan</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гаспарян Сусанна Арташесовна, д.м.н., проф., проф. кафедры акушерства, гинекологии и перинатологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Gasparyan Susanna A., DM Sci (habil.), professor, professor at Obstetrics, gynecology and perinatology Dept</p><p>Moscow</p></bio><email xlink:type="simple">prof-gasp55@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-8613-1548</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Топузов</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Topuzov</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Топузов Александр Георгиевич, аспирант кафедры акушерства и гинекологии с курсом ДПО</p><p>Ставрополь</p></bio><bio xml:lang="en"><p>Topuzov Alexander G., postgraduate student at Dept of Obstetrics and Gynecology with the course of Further professional education</p><p>Stavropol</p></bio><email xlink:type="simple">topuzov42@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6374-9786</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Василенко</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilenko</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Василенко Ирина Анатольевна, д.м.н., проф., зав. лабораторией биомедицинских методов исследований; проф. кафедры неорганической и аналитической химии</p><p>Москва</p></bio><bio xml:lang="en"><p>Vasilenko Irina A., DM Sci, professor, head of Biomedical Research Methods Laboratory;  professor at Inorganic and Analytical Chemistry Dept</p><p>Moscow</p></bio><email xlink:type="simple">vasilenko0604@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Государственный научный центр Российской Федерации – Федеральный медицинский биофизический центр имени А.И. Бурназяна», Медико-биологический университет инноваций и непрерывного образования</institution><country>Россия</country></aff><aff xml:lang="en"><institution>A.I. Burnazyan State Research and Development Center, Medical and Biological University of Innovation and Continuous Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ставропольский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБУЗ Московской области «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»; ФГБОУ ВО «Российский государственный университет имени А.Н. Косыгина (Технологии. Дизайн. Искусство)» Минобрнауки России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M. F. Vladimirsky Moscow Regional Clinical and Research Institute (MONIKI); Russian State University named after A.N. Kosygin</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>11</month><year>2024</year></pub-date><volume>0</volume><issue>19</issue><issue-title>Современная гинекология (2)</issue-title><fpage>33</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гаспарян С.А., Топузов А.Г., Василенко И.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Гаспарян С.А., Топузов А.Г., Василенко И.А.</copyright-holder><copyright-holder xml:lang="en">Gasparyan S.A., Topuzov A.G., Vasilenko I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/3908">https://www.med-alphabet.com/jour/article/view/3908</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Оценить особенности изменений морфофункционального статуса эритроцитов периферической крови при нормальной беременности и в условиях преэклампсии на основе экспресс-анализа биофизических показателей клеток.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследованы 136 беременных в сроке гестации 22–24 и 34–35 недель. Группы сравнения составили: 40 беременных с умеренной преэклампсией (ПЭ), 30 беременных с тяжелой преэклампсией, 30 беременных с хронической артериальной гипертензией (ХАГ), 36 женщин с нормально протекающей беременностью, не имеющих признаков гипертензивных расстройств. Электрокинетические особенности эритроцитов периферической крови исследовали методом клеточного микроэлектрофореза, анализировали среднее значение амплитуды колебаний подвижных эритроцитов (мкм) и долю подвижных клеток (%).</p></sec><sec><title>Результаты</title><p>Результаты. Всрок 22–24 недели убеременных сумеренной ПЭ% неподвижных эритроцитов повышался в 2,8 раза (p&lt;0,05), значения амплитуды колебаний подвижных клеток снижались на 21% (p&lt;0,05). У беременных с тяжелой ПЭ доля неподвижных эритроцитов увеличивалась в 3,2 раза (p&lt;0,05), амплитуда снижалась на 30% (p&lt;0,05). У беременных с ХАГ отмечено незначительное увеличение процента неподвижных клеток (8,2 vs 6,8%) и тенденция к снижению средней амплитуды (21,5 vs 23,2 мкм). В срок 34–35 недель в группе с умеренной ПЭ% неподвижных эритроцитов превышал соответствующий показатель женщин с физиологической беременностью в 3,3 раза (p&lt;0,05), средняя амплитуда снижалась на 28% (p&lt;0,05), у беременных с тяжелой ПЭ% неподвижных эритроцитов увеличился в 3,7 раза (p&lt;0,05), амплитуда снижалась на 36% (p&lt;0,05). У беременных с ХАГ сохранялась тенденция к незначительному увеличению доли неподвижных эритроцитов.</p></sec><sec><title>Заключение</title><p>Заключение. Функциональная и морфологическая полноценность эритроцитов как активных участников патогенеза преэклампсии может быть объективно оценена с использованием показателей электрокинетической активности клеток, а эритроциты можно рассматривать в качестве биомаркеров заболевания и перспективных инструментов стратификации пациенток для раннего выявления беременностей высокого риска.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To evaluate the features of changes in the morphofunctional status of peripheral blood erythrocytes during normal pregnancy and in preeclampsia based on rapid analysis of biophysical parameters of cells.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A total of 136 pregnant women were examined at 22–24 and 34–35 weeks of gestation. The comparison groups included: 40 pregnant women with moderate preeclampsia (PE), 30 pregnant women with severe preeclampsia, 30 pregnant women with chronic arterial hypertension (CAH), 36 women with normal pregnancy who do not have signs of hypertensive disorders. Electrokinetic features of peripheral blood erythrocytes were studied using cellular microelectrophoresis, the average value of the amplitude of oscillations of mobile erythrocytes (μm) and the proportion of mobile cells (%) were analyzed.</p></sec><sec><title>Results</title><p>Results. At 22–24 weeks, the percentage of immobile erythrocytes in pregnant women with moderate PE increased by 2.8 times (p&lt;0.05), the amplitude of oscillations of mobile cells decreased by 21% (p&lt;0.05). In pregnant women with severe PE, the proportion of immobile erythrocytes increased by 3.2 times (p&lt;0.05), the amplitude decreased by 30% (p&lt;0.05). In pregnant women with CAH, a slight increase in the percentage of immobile cells (8.2 vs 6.8%) and a tendency to a decrease in the average amplitude (21.5 vs 23.2 μm) were noted. At 34–35 weeks in the group with moderate PE, the% of immobile erythrocytes exceeded the corresponding indicator in women with physiological pregnancy by 3.3 times (p&lt;0.05), the average amplitude decreased by 28% (p&lt;0.05), in pregnant women with severe PE, the% of immobile erythrocytes increased by 3.7 times (p&lt;0.05), the amplitude decreased by 36% (p&lt;0.05). In pregnant women with CAH, there was a tendency for a slight increase in the proportion of immobile erythrocytes.</p></sec><sec><title>Conclusion</title><p>Conclusion. The functional and morphological usefulness of erythrocytes as active participants in the pathogenesis of preeclampsia can be objectively assessed using indicators of electrokinetic activity of cells, and erythrocytes can be considered as biomarkers of the disease and a promising tool for stratifying patients for early detection of high-risk pregnancies.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>преэклампсия</kwd><kwd>эритроцит</kwd><kwd>микроэлектрофорез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>preeclampsia</kwd><kwd>erythrocyte</kwd><kwd>microelectrophoresis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, Gotsch F, Erez O. The etiology of preeclampsia. Am J Obstet Gynecol. 2022 Feb; 226 (2S): S 844–S 866. DOI: 10.1016/j.ajog.2021.11.1356</mixed-citation><mixed-citation xml:lang="en">Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, Gotsch F, Erez O. The etiology of preeclampsia. Am J Obstet Gynecol. 2022 Feb; 226 (2S): S 844–S 866. DOI: 10.1016/j.ajog.2021.11.1356</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Долгополова Е. Л., Ломова Н. А., Караваева А. Л., Зубков В. В., Шмаков Р. Г. Тяжелая преэклампсия и задержка роста плода: отдаленные прогнозы для матерей и потомства. Акушерство и гинекология. 2020; 12: 100–107. DOI 10.18565/aig.2020.12.100–107</mixed-citation><mixed-citation xml:lang="en">Dolgopolova E. L., Lomova N. A., Karavaeva A. L., Zubkov V. V., Shmakov R. G. Severe preeclampsia and fetal growth restriction: long-term prognoses for mothers and offspring. Obstetrics and Gynecology. 2020; 12: 100–107. (In Russ.). DOI 10.18565/aig.2020.12.100–107</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ma’ayeh M, Costantine MM. Prevention of preeclampsia. Semin Fetal Neonatal Med. 2020; 25 (5): 101123. DOI: 10.1016/j.siny.2020.101123</mixed-citation><mixed-citation xml:lang="en">Ma’ayeh M, Costantine MM. Prevention of preeclampsia. Semin Fetal Neonatal Med. 2020; 25 (5): 101123. DOI: 10.1016/j.siny.2020.101123</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020; 76 (14): 1690–1702. DOI: 10.1016/j.jacc.2020.08.014</mixed-citation><mixed-citation xml:lang="en">Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2020; 76 (14): 1690–1702. DOI: 10.1016/j.jacc.2020.08.014</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am. J. Physiol. Renal. Physiol. 2020; 318 (6): F1315–F1326. DOI: 10.1152/ajprenal.00071.2020</mixed-citation><mixed-citation xml:lang="en">Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am. J. Physiol. Renal. Physiol. 2020; 318 (6): F1315–F1326. DOI: 10.1152/ajprenal.00071.2020</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Svigkou A, Katsi V, Kordalis VG, Tsioufis K. The Molecular Basis of the Augmented Cardiovascular Risk in Offspring of Mothers with Hypertensive Disorders of Pregnancy. Int J. Mol. Sci. 2024; 25 (10): 5455. DOI: 10.3390/ijms25105455</mixed-citation><mixed-citation xml:lang="en">Svigkou A, Katsi V, Kordalis VG, Tsioufis K. The Molecular Basis of the Augmented Cardiovascular Risk in Offspring of Mothers with Hypertensive Disorders of Pregnancy. Int J. Mol. Sci. 2024; 25 (10): 5455. DOI: 10.3390/ijms25105455</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? Am. J. Obstet. Gynecol. 2022; 226 (2S): S 954–S 962. DOI: 10.1016/j.ajog.2020.10.024</mixed-citation><mixed-citation xml:lang="en">Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? Am. J. Obstet. Gynecol. 2022; 226 (2S): S 954–S 962. DOI: 10.1016/j.ajog.2020.10.024</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yagel S, Cohen SM, Goldman-Wohl D. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Am. J. Obstet. Gynecol. 2022; 226 (2S): S 963–S 972. DOI: 10.1016/j.ajog.2020.10.023</mixed-citation><mixed-citation xml:lang="en">Yagel S, Cohen SM, Goldman-Wohl D. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Am. J. Obstet. Gynecol. 2022; 226 (2S): S 963–S 972. DOI: 10.1016/j.ajog.2020.10.023</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Uygur L, Kabasakal Ilter M, Helvacı N, Mokresh ME, Kahya M, Muvaffak E, Elmuhammed MH, Ayhan I, Kumru P. Investigating the blood rheology in the first trimester pregnancies with high risk for preeclampsia. Clin. Hemorheol. Microcirc. 2024; 86 (4): 519–530. DOI: 10.3233/CH‑232026</mixed-citation><mixed-citation xml:lang="en">Uygur L, Kabasakal Ilter M, Helvacı N, Mokresh ME, Kahya M, Muvaffak E, Elmuhammed MH, Ayhan I, Kumru P. Investigating the blood rheology in the first trimester pregnancies with high risk for preeclampsia. Clin. Hemorheol. Microcirc. 2024; 86 (4): 519–530. DOI: 10.3233/CH‑232026</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Сюндюкова Е. Г., Чулков В. С., Рябикина М. Г. Преэклампсия: современное состояние проблемы. Доктор.Ру. 2021; 20(1): 11–16. DOI: 10.31550/1727‑2378‑2021‑20‑1‑11‑16</mixed-citation><mixed-citation xml:lang="en">Syundyukova E. G., Chulkov V. S., Ryabikina M. G. Preeclampsia: current state of the problem. Doctor.Ru. 2021; 20(1): 11–16. (In Russ.). DOI: 10.31550/1727‑2378‑2021‑20‑1‑11‑16</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu’u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine. 2022; 75: 103780. DOI: 10.1016/j.ebiom.2021.103780</mixed-citation><mixed-citation xml:lang="en">MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu’u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine. 2022; 75: 103780. DOI: 10.1016/j.ebiom.2021.103780</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецова И. В. Роль преконцепционной эндотелиальной дисфункции в развитии акушерских осложнений. Медицинский алфавит. 2019; 1 (1): 53–58. https://doi.org/10.33667/2078‑5631‑2019‑1‑1(376)-53–58</mixed-citation><mixed-citation xml:lang="en">Kuznetsova I. V. Role ofpreconception endothelial dysfunction in development of obstetric complications. Medical alphabet. 2019; 1 (1): 53–58. (In Russ.). https://doi.org/10.33667/2078‑5631‑2019‑1‑1(376)-53–58</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, Alnaes-Katjavivi P, Sugulle M. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am. J. Obstet. Gynecol. 2022; 226 (2S): S 895–S 906. DOI: 10.1016/j.ajog.2020.09.026</mixed-citation><mixed-citation xml:lang="en">Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, Alnaes-Katjavivi P, Sugulle M. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am. J. Obstet. Gynecol. 2022; 226 (2S): S 895–S 906. DOI: 10.1016/j.ajog.2020.09.026</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mohaissen T, Proniewski B, Targosz-Korecka M, Bar A, Kij A, Bulat K, Wajda A, Blat A, Matyjaszczyk-Gwarda K, Grosicki M, Tworzydlo A, Sternak M, Wojnar-Lason K, Rodrigues-Diez R, Kubisiak A, Briones A, Marzec KM, Chlopicki S. Temporal relationship between systemic endothelial dysfunction and alterations in erythrocyte function in a murine model of chronic heart failure. Cardiovasc Res. 2022; 118(12): 2610–2624. DOI: 10.1093/cvr/cvab306</mixed-citation><mixed-citation xml:lang="en">Mohaissen T, Proniewski B, Targosz-Korecka M, Bar A, Kij A, Bulat K, Wajda A, Blat A, Matyjaszczyk-Gwarda K, Grosicki M, Tworzydlo A, Sternak M, Wojnar-Lason K, Rodrigues-Diez R, Kubisiak A, Briones A, Marzec KM, Chlopicki S. Temporal relationship between systemic endothelial dysfunction and alterations in erythrocyte function in a murine model of chronic heart failure. Cardiovasc Res. 2022; 118(12): 2610–2624. DOI: 10.1093/cvr/cvab306</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Alexandrova-Watanabe A, Abadjieva E, Giosheva I, Langari A, Tiankov T, Gartchev E, Komsa-Penkova R, Todinova S. Assessment of Red Blood Cell Aggregation in Preeclampsia by Microfluidic Image Flow Analysis-Impact of Oxidative Stress on Disease Severity. Int J. Mol. Sci. 2024; 25 (7): 3732. DOI: 10.3390/ijms25073732</mixed-citation><mixed-citation xml:lang="en">Alexandrova-Watanabe A, Abadjieva E, Giosheva I, Langari A, Tiankov T, Gartchev E, Komsa-Penkova R, Todinova S. Assessment of Red Blood Cell Aggregation in Preeclampsia by Microfluidic Image Flow Analysis-Impact of Oxidative Stress on Disease Severity. Int J. Mol. Sci. 2024; 25 (7): 3732. DOI: 10.3390/ijms25073732</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sachan R, Patel ML, Vandana, Sachan P, Shyam R. Role of platelet count and mean platelet volume and red cell distribution width in the prediction of preeclampsia in early pregnancy. J. Family Med. Prim Care. 2021; 10 (2): 838–843. DOI: 10.4103/jfmpc.jfmpc_1528_20</mixed-citation><mixed-citation xml:lang="en">Sachan R, Patel ML, Vandana, Sachan P, Shyam R. Role of platelet count and mean platelet volume and red cell distribution width in the prediction of preeclampsia in early pregnancy. J. Family Med. Prim Care. 2021; 10 (2): 838–843. DOI: 10.4103/jfmpc.jfmpc_1528_20</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Садов Р. И., Баев Т. О., Панова И. А., Назаров С. Б., Кузьменко Г. Н. Особенности морфометрических изменений тромбоцитов и эритроцитов у женщин с различными формами гипертензивных расстройств в III триместре беременности. Acta biomedica scientifica. 2020; 5 (5): 31–38. DOI: 10.29413/ABS.2020–5.5.4</mixed-citation><mixed-citation xml:lang="en">Sadov R. I., Baev T. O., Panova I. A., Nazarov S. B., Kuzmenko G. N. Features of morphometric changes in platelets and erythrocytes in women with various forms of hypertensive disorders in the third trimester of pregnancy. Acta biomedica scientifica. 2020; 5 (5): 31–38. (In Russ.). DOI: 10.29413/ABS.2020–5.5.4</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Smith C, Teng F, Branch E, Chu S, Joseph KS. Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy. Obstet Gynecol. 2019; 134(6): 1234–1244. DOI: 10.1097/AOG.0000000000003557</mixed-citation><mixed-citation xml:lang="en">Smith C, Teng F, Branch E, Chu S, Joseph KS. Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy. Obstet Gynecol. 2019; 134(6): 1234–1244. DOI: 10.1097/AOG.0000000000003557</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Chandrasekaran S, Simon R. Hepatic Complications in Preeclampsia. Clin Obstet Gynecol. 2020; 63 (1): 165–174. DOI: 10.1097/GRF.0000000000000501. PMID: 31770122.</mixed-citation><mixed-citation xml:lang="en">Chandrasekaran S, Simon R. Hepatic Complications in Preeclampsia. Clin Obstet Gynecol. 2020; 63 (1): 165–174. DOI: 10.1097/GRF.0000000000000501. PMID: 31770122.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kontidou E, Collado A, Pernow J, Zhou Z. Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease. Arterioscler Thromb Vasc Biol. 2023; 43 (5): 628–636. DOI: 10.1161/ATVBAHA.123.319027</mixed-citation><mixed-citation xml:lang="en">Kontidou E, Collado A, Pernow J, Zhou Z. Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease. Arterioscler Thromb Vasc Biol. 2023; 43 (5): 628–636. DOI: 10.1161/ATVBAHA.123.319027</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Баев Т. О., Панова И. А., Кузьменко Г. Н., Клычева М. М., Назаров С. Б. Состояние микроциркуляции у беременных женщин с гипертензивными расстройствами в III триместре беременности. Научные результаты биомедицинских исследований. 2023; 9 (1): 113–128. DOI: 10.18413/2658‑6533‑2023‑9‑1‑0‑8</mixed-citation><mixed-citation xml:lang="en">Baev T. O., Panova I. A., Kuzmenko G. N., Klycheva M. M., Nazarov S. B. State of microcirculation in pregnant women with hypertensive disorders in the third trimester of pregnancy. Scientific results of biomedical research. 2023; 9 (1): 113–128. (In Russ.). DOI: 10.18413/2658‑6533‑2023‑9‑1‑0‑8</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Csiszar B, Galos G, Funke S, Kevey DK, Meggyes M, Szereday L, Kenyeres P, Toth K, Sandor B. Peripartum Investigation of Red Blood Cell Properties in Women Diagnosed with Early-Onset Preeclampsia. Cells. 2021; 10 (10): 2714. DOI: 10.3390/cells10102714</mixed-citation><mixed-citation xml:lang="en">Csiszar B, Galos G, Funke S, Kevey DK, Meggyes M, Szereday L, Kenyeres P, Toth K, Sandor B. Peripartum Investigation of Red Blood Cell Properties in Women Diagnosed with Early-Onset Preeclampsia. Cells. 2021; 10 (10): 2714. DOI: 10.3390/cells10102714</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">McCann Haworth SM, Zhuge Z, Nihlén C, Von Rosen MF, Weitzberg E, Lundberg JO, Krmar RT, Nasiell J, Carlström M. Red blood cells from patients with pre-eclampsia induce endothelial dysfunction. J. Hypertens. 2021; 39 (8): 1628–1641. DOI: 10.1097/HJH.0000000000002834</mixed-citation><mixed-citation xml:lang="en">McCann Haworth SM, Zhuge Z, Nihlén C, Von Rosen MF, Weitzberg E, Lundberg JO, Krmar RT, Nasiell J, Carlström M. Red blood cells from patients with pre-eclampsia induce endothelial dysfunction. J. Hypertens. 2021; 39 (8): 1628–1641. DOI: 10.1097/HJH.0000000000002834</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Giosheva I, Strijkova V, Komsa-Penkova R, Krumova S, Langari A, Danailova A, Taneva SG, Stoyanova T, Topalova L, Gartchev E, Georgieva G, Todinova S. Membrane Lesions and Reduced Life Span of Red Blood Cells in Preeclampsia as Evidenced by Atomic Force Microscopy. Int J. Mol. Sci. 2023; 24 (8): 7100. DOI: 10.3390/ijms24087100</mixed-citation><mixed-citation xml:lang="en">Giosheva I, Strijkova V, Komsa-Penkova R, Krumova S, Langari A, Danailova A, Taneva SG, Stoyanova T, Topalova L, Gartchev E, Georgieva G, Todinova S. Membrane Lesions and Reduced Life Span of Red Blood Cells in Preeclampsia as Evidenced by Atomic Force Microscopy. Int J. Mol. Sci. 2023; 24 (8): 7100. DOI: 10.3390/ijms24087100</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Soliman AA, Csorba R, Yilmaz A, Tsikoaras P, von Tempelhoff GF. Rheologic results and their correlation to hemostatic changes in patients with moderate and severe preeclampsia: an observational cross-sectional study. Clin. Hemorheol Microcirc. 2015; 59 (1): 1–15. DOI: 10.3233/CH‑2012–1625</mixed-citation><mixed-citation xml:lang="en">Soliman AA, Csorba R, Yilmaz A, Tsikoaras P, von Tempelhoff GF. Rheologic results and their correlation to hemostatic changes in patients with moderate and severe preeclampsia: an observational cross-sectional study. Clin. Hemorheol Microcirc. 2015; 59 (1): 1–15. DOI: 10.3233/CH‑2012–1625</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Меджидова Д. Р., Шифман Е. М., Абдуллаев В. Р., Муслимов М. О. Изменения свойств эритроцитов крови у родительниц после кесарева сечения в зависимости от метода ведения периоперационного периода. Доктор.Ру. 2023; 22 (1): 56–61. DOI: 10.31550/1727‑2378‑2023‑22‑1‑56‑61</mixed-citation><mixed-citation xml:lang="en">Меджидова Д. Р., Шифман Е. М., Абдуллаев В. Р., Муслимов М. О. Изменения свойств эритроцитов крови у родительниц после кесарева сечения в зависимости от метода ведения периоперационного периода. Доктор.Ру. 2023; 22 (1): 56–61. DOI: 10.31550/1727‑2378‑2023‑22‑1‑56‑61</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Medzhidova D. R., Shifman E. M., Abdullaev V. R., Muslimov M. O. Changes in the properties of blood erythrocytes in mothers after cesarean section depending on the method of perioperative period management. Doctor.Ru. 2023; 22 (1): 56–61. (In Russ.). DOI: 10.31550/1727‑2378‑2023‑22‑1‑56‑61</mixed-citation><mixed-citation xml:lang="en">Medzhidova D. R., Shifman E. M., Abdullaev V. R., Muslimov M. O. Changes in the properties of blood erythrocytes in mothers after cesarean section depending on the method of perioperative period management. Doctor.Ru. 2023; 22 (1): 56–61. (In Russ.). DOI: 10.31550/1727‑2378‑2023‑22‑1‑56‑61</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Зобова Д. А., Власова Т. И., Ледяйкина Л. В., Маркина А. Е., Щекина С. А. Модификация фосфолипидного состава мембран эритроцитов и изменений структурно-функционального состояния гемоглобина в развитии гипоксии плода при преэклампсии. Медико-фармацевтический журнал «Пульс». 2020; 22 (2): 71–76. DOI: 10.26787/nydha‑2686‑6838‑2020‑22‑2‑71‑76</mixed-citation><mixed-citation xml:lang="en">Zobova D. A., Vlasova T. I., Ledyaykina L. V., Markina A. E., Shchekina S. A. Modification of the phospholipid composition of erythrocyte membranes and changes in the structural and functional state of hemoglobin in the development of fetal hypoxia in preeclampsia. Medical and pharmaceutical journal «Pulse». 2020; 22 (2): 71–76. (In Russ.). DOI: 10.26787/nydha‑2686‑6838‑2020‑22‑2‑71‑76</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sen P, Ghosh D, Sarkar C. Erythrocytic membrane anionic charge, sialic acid content, and their correlations with urinary glycosaminoglycans in preeclampsia and eclampsia. Scand J. Clin. Lab. Invest. 2020; 80 (4): 343–347. DOI: 10.1080/00365513.2020.1750687</mixed-citation><mixed-citation xml:lang="en">Sen P, Ghosh D, Sarkar C. Erythrocytic membrane anionic charge, sialic acid content, and their correlations with urinary glycosaminoglycans in preeclampsia and eclampsia. Scand J. Clin. Lab. Invest. 2020; 80 (4): 343–347. DOI: 10.1080/00365513.2020.1750687</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
